Literature DB >> 26335948

Alkoxide coordination of iron(III) protoporphyrin IX by antimalarial quinoline methanols: a key interaction observed in the solid-state and solution.

Johandie Gildenhuys1, Chandre J Sammy, Ronel Müller, Victor A Streltsov, Tanya le Roex, David Kuter, Katherine A de Villiers.   

Abstract

The quinoline methanol antimalarial drug mefloquine is a structural analogue of the Cinchona alkaloids, quinine and quinidine. We have elucidated the single crystal X-ray diffraction structure of the complexes formed between racemic erythro mefloquine and ferriprotoporphyrin IX (Fe(iii)PPIX) and show that alkoxide coordination is a key interaction in the solid-state. Mass spectrometry confirms the existence of coordination complexes of quinine, quinidine and mefloquine to Fe(iii)PPIX in acetonitrile. The length of the iron(iii)-O bond in the quinine and quinidine complexes as determined by Extended X-ray Absorption Fine Structure (EXAFS) spectroscopy unequivocally confirms that coordination of the quinoline methanol compounds to Fe(iii)PPIX occurs in non-aqueous aprotic solution via their benzylic alkoxide functional group. UV-visible spectrophotometric titrations of the low-spin bis-pyridyl-Fe(iii)PPIX complex with each of the quinoline methanol compounds results in the displacement of a single pyridine molecule and subsequent formation of a six-coordinate pyridine-Fe(iii)PPIX-drug complex. We propose that formation of the drug-Fe(iii)PPIX coordination complexes is favoured in a non-aqueous environment, such as that found in lipid bodies or membranes in the malaria parasite, and that their existence may contribute to the mechanism of haemozoin inhibition or other toxicity effects that lead ultimately to parasite death. In either case, coordination is a key interaction to be considered in the design of novel antimalarial drug candidates.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26335948     DOI: 10.1039/c5dt02671g

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  6 in total

1.  Hemozoin inhibiting 2-phenylbenzimidazoles active against malaria parasites.

Authors:  Fabrizio P L'abbate; Ronel Müller; Roxanne Openshaw; Jill M Combrinck; Katherine A de Villiers; Roger Hunter; Timothy J Egan
Journal:  Eur J Med Chem       Date:  2018-09-28       Impact factor: 6.514

2.  Intrinsic fluorescence properties of antimalarial pyrido[1,2-a]benzimidazoles facilitate subcellular accumulation and mechanistic studies in the human malaria parasite Plasmodium falciparum.

Authors:  Constance M Korkor; Larnelle F Garnie; Leah Amod; Timothy J Egan; Kelly Chibale
Journal:  Org Biomol Chem       Date:  2020-11-04       Impact factor: 3.876

3.  Novel Antimalarial Tetrazoles and Amides Active against the Hemoglobin Degradation Pathway in Plasmodium falciparum.

Authors:  Aloysus Lawong; Suraksha Gahalawat; John Okombo; Josefine Striepen; Tomas Yeo; Sachel Mok; Ioanna Deni; Jessica L Bridgford; Hanspeter Niederstrasser; Anwu Zhou; Bruce Posner; Sergio Wittlin; Francisco Javier Gamo; Benigno Crespo; Alisje Churchyard; Jake Baum; Nimisha Mittal; Elizabeth Winzeler; Benoît Laleu; Michael J Palmer; Susan A Charman; David A Fidock; Joseph M Ready; Margaret A Phillips
Journal:  J Med Chem       Date:  2021-02-23       Impact factor: 7.446

Review 4.  Heme Detoxification in the Malaria Parasite: A Target for Antimalarial Drug Development.

Authors:  Katherine A de Villiers; Timothy J Egan
Journal:  Acc Chem Res       Date:  2021-05-13       Impact factor: 24.466

Review 5.  A Review of Modifications of Quinoline Antimalarials: Mefloquine and (hydroxy)Chloroquine.

Authors:  Dawid J Kucharski; Michalina K Jaszczak; Przemysław J Boratyński
Journal:  Molecules       Date:  2022-02-02       Impact factor: 4.411

6.  Nanocrystallography measurements of early stage synthetic malaria pigment.

Authors:  Ruben A Dilanian; Victor Streltsov; Hannah D Coughlan; Harry M Quiney; Andrew V Martin; Nectarios Klonis; Con Dogovski; Sébastien Boutet; Marc Messerschmidt; Garth J Williams; Sophie Williams; Nicholas W Phillips; Keith A Nugent; Leann Tilley; Brian Abbey
Journal:  J Appl Crystallogr       Date:  2017-09-28       Impact factor: 3.304

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.